GENOMIC HEALTH INC - COM (GHDX)

CUSIP: 37244C101

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
27,543,448
Share change
+45,787
Total reported value
$806,254,818
Put/Call ratio
311%
Price per share
$29.27
Number of holders
117
Value change
+$1,339,678
Number of buys
2
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 37244C101?
CUSIP 37244C101 identifies GHDX - GENOMIC HEALTH INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of GENOMIC HEALTH INC - COM (GHDX) as of Q4 2013

As of 31 Dec 2013, GENOMIC HEALTH INC - COM (GHDX) was held by 117 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 27,543,448 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, Champlain Investment Partners, LLC, BAILLIE GIFFORD & CO, LORD, ABBETT & CO. LLC, TPG Group Holdings (SBS) Advisors, Inc., VANGUARD GROUP INC, BlackRock Fund Advisors, State Street Corp, and BlackRock Institutional Trust Company, N.A.. This page lists 117 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.